International Flavors & Fragrances Inc.

(New York Stock Exchange)
Back to all articles
Bullish +65

Key facts: IFF Beats Q3; Raises Outlook, Completes Buyback - TradingView

Divestiture Earnings report Share buyback AI-generated analysis

πŸ“ˆ IFF reported Q3 2026 sales of $1.942 billion, representing a 4% year-over-year increase.

πŸ’° Adjusted EBITDA reached $403 million in the quarter, marking a 5% increase from the prior year.

πŸš€ The company beat both sales and adjusted EPS expectations driven by broad-based volume growth.

πŸ‘ƒ Scent division adjusted EBITDA surged 10%, leading segment performance alongside 7% growth in Taste.

πŸ’Έ IFF completed its $500 million accelerated share repurchase program to return capital to shareholders.

🏭 The Food Ingredients business was classified as discontinued operations with a sale expected to close in Q2 2027.

πŸ“ˆ Analysts raised the average 12-month price target to $98.25, implying about 7% upside from recent levels.

⚠️ Management flagged lower Q4 profitability due to higher costs and reinvestment needs in Health & Biosciences.

πŸ—“οΈ The planned separation of the Food Ingredients unit remains on schedule for completion by end of Q2 2027.

Bullish Signals
  • IFF beat third-quarter sales and adjusted EPS expectations driven by broad-based volume growth across its divisions.
  • Segment adjusted EBITDA rose 6% overall, led by a strong 10% growth in the Scent division and 7% in Taste.
  • Analysts raised their average 12-month price target to $98.25 from $97.62, implying approximately 7% upside from the Nov. 3 close.
  • The company successfully completed its $500 million accelerated share repurchase program.
  • Currency-neutral sales growth was reported across Taste, Scent, and Health & Biosciences segments.
Risk Factors
  • Management flagged lower Q4 profitability expectations due to higher costs and reinvestment needs in the Health & Biosciences segment.
  • The sale of the Food Ingredients business will be classified as discontinued operations, impacting reported results until the deal closes in Q2 2027.
Full Analysis
International Flavors & Fragrances (IFF) reported strong third-quarter 2026 results, posting sales of $1.942 billion, a 4% year-over-year increase, and adjusted EBITDA of $403 million, up 5%. The company beat both sales and adjusted earnings per share expectations, driven by broad-based volume growth across its core divisions. Segment performance was particularly robust in the Scent division, which saw adjusted EBITDA rise 10%, while the Taste division grew 7%. Currency-neutral sales growth was reported across all major segments including Health & Biosciences. Analysts have responded positively to the results, raising their average 12-month price target to $98.25 from $97.62, implying approximately 7% upside from the November 3 closing price. Strategically, IFF completed its $500 million accelerated share repurchase program and agreed to sell its Food Ingredients business, with the transaction expected to close by the end of Q2 2027. While management flagged lower profitability in the fourth quarter due to higher costs and reinvestment needs in Health & Biosciences, the company maintains that its planned separation of the Food Ingredients unit remains on schedule for completion. Market sentiment remains bullish with a consensus Buy rating among 16 analysts covering the stock. The price target range spans from $76 to $110, reflecting confidence in IFF's ability to navigate near-term margin pressures while executing its long-term growth strategy through organic volume gains and strategic divestitures.